Table 1.
All Patients | ICB Subgroups | |||
---|---|---|---|---|
ICB | No ICB | p-value | ||
Sample Size | 38 | 19 | 19 | |
Age (yrs) | 62.1 (7.0) | 60.9 (5.6) | 63.2 (8.1) | >.10 |
Gender (M:F) | 19:19 | 10:9 | 9:10 | >.10 |
Education (yrs) | 16.6 (2.6) | 16.8 (2.3) | 16.4 (2.9) | >.10 |
MMSE | 28.8 (1.5) | 28.8 (1.5) | 28.8 (1.5) | >.10 |
Disease Duration (yrs) | 7.6 (5.9) | 9.4 (6.8) | 5.9 (4.3) | .06 |
UPDRS Motor Score | 16.8 (8.1) | 18.4 (7.4) | 15.3 (8.6) | >.10 |
Agonist LEDD (mg) | 247 (138) | 277 (145) | 218 (128) | >.10 |
Agonist Duration (yrs) | 3.7 (3.6) | 4.6 (4.0) | 2.8 (2.9) | >.10 |
Daily Levodopa (mg) | -- | 584 (270) (n = 13) |
618 (220) (n = 10) |
>.10 |
MMSE = Mini-Mental Status Exam; UPDRS = Unified Parkinson’s Disease Rating Scale; LEDD = Levodopa Equivalent Daily Dosage (in mg); ICB = Impulse-Compulsive Behaviors